MARKET

MCRB

MCRB

Seres
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.520
+0.070
+2.03%
Closed 16:00 01/23 EST
OPEN
3.450
PREV CLOSE
3.450
HIGH
3.620
LOW
3.350
VOLUME
377.53K
TURNOVER
--
52 WEEK HIGH
8.39
52 WEEK LOW
2.020
MARKET CAP
246.44M
P/E (TTM)
-2.2183
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MCRB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MCRB News

  • Did You Manage To Avoid Seres Therapeutics's (NASDAQ:MCRB) Painful 66% Share Price Drop?
  • Simply Wall St..6d ago
  • Hedge Funds Are Dumping Seres Therapeutics Inc (MCRB)
  • Insider Monkey.12/20/2019 22:04
  • Flagship Unveils Newest Pioneering Platform: Ring Therapeutics
  • PR Newswire.12/19/2019 13:00
  • Seres Therapeutics Appoints Stephen Berenson as Chairman of its Board of Directors
  • Business Wire.12/16/2019 12:00

More

Industry

Biotechnology & Medical Research
-1.13%
Pharmaceuticals & Medical Research
-0.52%

Hot Stocks

Name
Price
%Change

About MCRB

Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens.
More

Webull offers Seres Therapeutics Inc (MCRB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.